The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
What new treatments are there for relapsed acute myeloid leukemia?
Jorge Sierra
March 14, 2022
During the ESH 3rd How to Diagnose and Treat Acute Leukaemias, Know AML was pleased to speak with Jorge Sierra, Hospital de la Santa Creu i Sant Pau, Barcelona, ES. We asked, What new treatments are there for relapsed acute myeloid leukemia?
Sierra begins by outlining new chemotherapy combinations, including recently approved agents like venetoclax and CPX-351. He highlights the importance of venetoclax, and immunotherapies and combinations with molecular agents. He goes on to discuss the role of CAR T-cells and allogeneic transplants in acute myeloid leukemia treatment.
To what extent do you agree with the following statements?
Please rate between 1 and 5, with 1 being 'strongly disagree' and 5 being 'strongly agree'.
